Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo

Asher Kornbluth, MD, New York

Long Island Clinical Research Associates, Great Neck

Rochester General Hospital, Rochester

Advanced Gastroenterology Associates, Suwanee

Atlanta Gastroenterology Associates, Atlanta

Gastroenterology Associates, Bristol

Gastroenterology Associates, Kingsport

Northwestern University, Chicago

Institute of Healthcare Assessment, San Diego

University of California, San Francisco, San Francisco

Cliniques Universitaires Saint-Luc, Brussels

Academic Hospital Gasthuisberg, Leuven

Benjamin Franklin University, Berlin

Medizinischen Hochschule-Hannover, Hanover

Universitats Klinikum Heidelberg, Heidelberg

University of Kiel, Kiel

Gastroenterologische Fachpraxis, Minden

Stadtisches Krankenhaus Munchen-Bogenhausen, München

University of Munster, Münster

Rambam Medical Center, Haifa

Hadassah Medical Center, Jerusalem

Shaare Zedek Hospital, Jerusalem

Tel Aviv Sourasky Medical Center, Tel Aviv

Chaim Sheba Medical Center, Tel Litwinsky

Academic Medical Center, Amsterdam

Free University (Vrije Universiteit), Amsterdam

Academisch Ziekenhuis Maastricht, Maastricht

Erasmus Medical Center, Rotterdam